1.Tice, AD, et al. (2004) Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 38(12), 1651–1672.
2.Williams, DN, et al. (1997) Practice guidelines for community-based parenteral anti-infective therapy. ISDA practice guidelines committee. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 25(4), 787–801.
3.Seaton, RA and Barr, DA (2013) Outpatient parenteral antibiotic therapy: principles and practice. European Journal of Internal Medicine 24(7), 617–623.
4.Chapman, AL, et al. (2009) Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. Journal of Antimicrobial Chemotherapy 64(6), 1316–1324.
5.Wai, AO, et al. (2000) Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and ministry of health perspective. PharmacoEconomics 18(5), 451–457.
6.Yan, M, et al. (2016) Patient characteristics and outcomes of outpatient parenteral antimicrobial therapy: a retrospective study. Canadian Journal of Infectious Diseases and Medical Microbiology 2016, 5.
7.Means, L, et al. (2016) Predictors of hospital readmission in patients receiving outpatient parenteral antimicrobial therapy. Pharmacotherapy 36(8), 934–939.
8.Allison, GM, et al. (2014) Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 58(6), 812–819.
9.Harris, PA, et al. (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 42(2), 377–381.
10.Charlson, ME, et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40(5), 373–383.
11.Chopra, V, et al. (2015) Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: a nested case-control study. Thrombosis Research 135(5), 829–834.
12.Duncan, CJA, et al. (2013) Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis. Journal of Antimicrobial Chemotherapy 68(7), 1650–1654.
13.Huck, D, et al. (2014) Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme. Journal of Antimicrobial Chemotherapy 69(1), 228–233.
14.Goodwin, AJ, et al. (2015) Frequency, cost and risk factors of readmissions among severe sepsis survivors. Critical Care Medicine 43(4), 738–746.
15.Nkemdirim Okere, A and Renier, CM (2015) Effects of statins on hospital length of stay and All-cause readmissions Among hospitalized patients With a primary diagnosis of sepsis. Annals of Pharmacotherapy 49(12), 1273–1283.
16.Patel, JM, et al. (2012) Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS trial). Critical Care 16(6), R231.
17.Mosher, HJ, et al. (2014) Prevalence and characteristics of hospitalized adults on chronic opioid therapy. Journal of Hospital Medicine 9(2), 82–87.